Search Results

Doxil (doxorubicin HCl liposome injection) for Hospital Care

Doxil  (doxorubicin HCl liposome injection) is indicated for treatment of ovarian cancer, acquired immune deficiency syndrome (AIDS)-related Kaposi’s Sarcoma, and multiple myeloma.

Tobi Karchmer, M.D., M.S.

Tobi Karchmer, M.D., M.S., is senior vice president and chief medical and scientific officer. Prior to her appointment to chief medical officer in 2021, Karchmer served as vice president, Worldwide Medical, which consists of Baxter's Global and Regional Medical Affairs teams, Clinical Research team and Strategy and Delivery team.

James Borzi

James Borzi is executive vice president, chief supply chain officer. Borzi joined Baxter in August 2020 from GE Healthcare, where he served as vice president, chief supply chain officer from 2019 to 2020. Prior to joining GE Healthcare, he spent five years with Becton Dickinson (BD) in various manufacturing operations leadership roles; his last role with BD was executive vice president of Global Operations and chief supply chain officer.

Olimel Portfolio

The Olimel portfolio consists of eight unique olive oil-based parenteral (intravenous) nutrition formulations designed to match the personalized protein and energy needs of patients.

Patricia B. Morrison

Patricia B. Morrison has served as a director of Baxter since 2019.

Amy A. Wendell

Amy A. Wendell has served as a director of Baxter since 2019.

Heather Knight

Heather Knight was named Baxter’s executive vice president and chief operating officer (COO) in February 2025 and currently also serves as interim group president, Medical Products and Therapies (MPT).